zutectra solution for injection 500 iuml
eshcol pharmaceutical group singapore pte ltd - human hepatitis b immunoglobulin in 150g/l human plasma protein (igg ≥ 96%) - injection - 500 iu/ml - human hepatitis b immunoglobulin in 150g/l human plasma protein (igg ≥ 96%) 500 iu/ml
batrafen nail lacquer
pharma shalom - ciclopirox - lacque - ciclopirox 80 mg/g - ciclopirox - ciclopirox - for the treatment of fungal infections of the nails.
biotest
alphakrust ltd, tanzania - biotest sulphite -
megalotect cp solution for infusion 100 uml
grifols asia pacific pte. ltd. - human cytomegalovirus immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) - injection - 100 u/ml - human cytomegalovirus immunoglobulin in 50mg/ml human plasma protein (igg ≥ 96%) 100 u/ml
haemoctin sdh 500 for injection 500 iuvial
grifols asia pacific pte. ltd. - human coagulation factor viii - injection, powder, lyophilized, for solution - 500iu/vial - human coagulation factor viii 500iu/vial
haemoctin sdh 1000 for injection 1000 iuvial
grifols asia pacific pte. ltd. - human coagulation factor viii - injection, powder, lyophilized, for solution - human coagulation factor viii 1000 iu/vial
haemoctin sdh 250 for injection 250 iuvial
grifols asia pacific pte. ltd. - human blood coagulation factor viii - injection, powder, for solution - 250 iu/vial - human blood coagulation factor viii 250 iu/vial
intratect solution for infusion 50gl
grifols asia pacific pte. ltd. - human normal immunoglobulin (human plasma protein containing at least 96% immunoglobulin) - infusion, solution - 50 mg/ml - human normal immunoglobulin (human plasma protein containing at least 96% immunoglobulin) 50 mg/ml
haemoctin sdh 250 iu
kamada ltd, israel - human plasma coagulation factor viii - powder for solution for injection - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency. haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.
haemoctin sdh 500 iu
kamada ltd, israel - human plasma coagulation factor viii - powder and solvent for solution for injection - human plasma coagulation factor viii 50 iu/ml - coagulation factor viii - coagulation factor viii - treatment and prophylaxis of bleeding: in patients with haemophilia a (congenital factor viii deficiency) in patient with acquired factor viii deficiency.haemoctin is not effective in controlling the bleeding of patients with von willebrond`s disease.